Insights

Innovative Technology MILabs specializes in high-performance, multimodal preclinical imaging systems that combine SPECT, PET, CT, and Optical imaging, offering comprehensive and data-rich diagnostics. This positions the company to provide advanced solutions for clients seeking cutting-edge imaging technology for disease research and therapy development.

Global Collaboration With over 300 imaging modules installed worldwide and partnerships with leading academic institutions, hospitals, and pharmaceutical companies, MILabs demonstrates strong market presence and a vast network of potential clients interested in enhancing their molecular imaging capabilities.

Recent Corporate Growth The acquisitions by Rigaku Corporation and Bayer AG highlight strategic growth and validation of MILabs' innovative imaging systems. These corporate moves create opportunities for upselling advanced systems and expanding product offerings to a broader customer base involved in preclinical research.

Focus on Diagnostics MILabs' development of diagnostic probes and specialized imaging platforms aimed at biofunctional analysis indicates potential for cross-selling targeted diagnostics tools and supporting research organizations focused on disease detection and therapy monitoring.

Funding and Revenue Potential Although current revenue is between one and ten million dollars, MILabs' differentiation through multimodal imaging and recent acquisition activities suggest significant growth opportunities. Selling advanced imaging modules, maintenance services, and ongoing upgrades could help tap into this expanding market segment.

MILabs Tech Stack

MILabs uses 8 technology products and services including Cloudflare, Font Awesome, TweenMax, and more. Explore MILabs's tech stack below.

  • Cloudflare
    Content Management System
  • Font Awesome
    Font Scripts
  • TweenMax
    Javascript Frameworks
  • Element UI
    Javascript Frameworks
  • LinkedIn
    Online Community Software
  • Elementor
    Page Builders
  • New Relic
    Real User Monitoring
  • Twitter
    Widgets

Media & News

MILabs's Email Address Formats

MILabs uses at least 1 format(s):
MILabs Email FormatsExamplePercentage
F.Last@milabs.comJ.Doe@milabs.com
42%
First@milabs.comJohn@milabs.com
22%
FLast@milabs.comJDoe@milabs.com
21%
First.Last@milabs.comJohn.Doe@milabs.com
15%

Frequently Asked Questions

Where is MILabs's headquarters located?

Minus sign iconPlus sign icon
MILabs's main headquarters is located at 7a Duwboot Houten, Utrecht 3991 cd Netherlands. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is MILabs's official website and social media links?

Minus sign iconPlus sign icon
MILabs's official website is milabs.com and has social profiles on LinkedInCrunchbase.

What is MILabs's SIC code NAICS code?

Minus sign iconPlus sign icon
MILabs's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MILabs have currently?

Minus sign iconPlus sign icon
As of February 2026, MILabs has approximately 60 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: T. V. E.Chief Operating Officer: R. J. S.Principal Imaging Scientist / Business Director: C. W.. Explore MILabs's employee directory with LeadIQ.

What industry does MILabs belong to?

Minus sign iconPlus sign icon
MILabs operates in the Biotechnology Research industry.

What technology does MILabs use?

Minus sign iconPlus sign icon
MILabs's tech stack includes CloudflareFont AwesomeTweenMaxElement UILinkedInElementorNew RelicTwitter.

What is MILabs's email format?

Minus sign iconPlus sign icon
MILabs's email format typically follows the pattern of F.Last@milabs.com. Find more MILabs email formats with LeadIQ.

MILabs

Biotechnology ResearchUtrecht, Netherlands51-200 Employees

MILabs provides high performance standalone and integrated preclinical SPECT, PET, CT and Optical Imaging systems for molecular imaging and in vivo imaging research. The 4x4D multimodal imaging technology, each with four-dimensional imaging capabilities enables researchers to improve diagnostics and therapy development through complementary, data-rich, co-registered images. Each modality by itself gives data beyond the capabilities of any other stand-alone system. 

Our mission is to make molecular imaging clear. Through continuous innovation and supportive service, the team at MILabs is dedicated to ‘providing small details for big discoveries’ for a wide range of imaging research programs.  With over 300 imaging modules installed worldwide, our fast-growing company collaborates with leading universities, hospitals, contract research organizations and pharmaceutical companies.  The systems contribute significantly to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases.

Explore how the cutting-edge preclinical imaging and clinical technologies can accelerate research discoveries at www.milabs.com

Section iconCompany Overview

Headquarters
7a Duwboot Houten, Utrecht 3991 cd Netherlands
Website
milabs.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    MILabs's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    MILabs's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.